all

We are sad to report that we learned last week that Dr. Roger Illingworth passed away in early November after a long illness. He was a founding member of the NLA Board. Dr. Illingworth’s  career was dedicated to understanding, preventing and treating patients with cholesterol and lipid disorders and heart disease, and his research was instrumental in the development of the statin drugs from the earliest days. Our thoughts and prayers go out to Dr. Illingworth’s family.

2014 NLA Honors & Awards

To honor the exceptional professionals in our ranks, the NLA has established several types of recognition. We are currently seeking nominations for the following awards, to be presented at the 2014 Annual Scientific Sessions in Orlando, Florida (May 1-4, 2014):

Fellow of the NLA 

The National Lipid Association along with a panel of outside experts from various disciplines convened for a workshop in late July to examine how health information technology (HIT) can be used, to effectively improve LDL-C goal attainment. The workshop committee of experts included participants from academic medical centers, health care policy organizations, large health care systems, as well as members from the HIT and pharmaceutical industries.